These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 20012407)
41. A translational research framework for enhanced validity of mouse models of psychopathological states in depression. Pryce CR; Seifritz E Psychoneuroendocrinology; 2011 Apr; 36(3):308-29. PubMed ID: 20538414 [TBL] [Abstract][Full Text] [Related]
42. Neurodegenerative tauopathies: human disease and transgenic mouse models. Lee VM; Trojanowski JQ Neuron; 1999 Nov; 24(3):507-10. PubMed ID: 10595503 [No Abstract] [Full Text] [Related]
43. Modelling early responses to neurodegenerative mutations in mice. Gilley J; Adalbert R; Coleman MP Biochem Soc Trans; 2011 Aug; 39(4):933-8. PubMed ID: 21787326 [TBL] [Abstract][Full Text] [Related]
44. Neurobehavioral tests in rat models of degenerative brain diseases. Urbach YK; Bode FJ; Nguyen HP; Riess O; von Hörsten S Methods Mol Biol; 2010; 597():333-56. PubMed ID: 20013245 [TBL] [Abstract][Full Text] [Related]
45. Practical considerations of genetic rodent models for neurodegenerative diseases. Geghman K; Li C Methods Mol Biol; 2011; 793():185-93. PubMed ID: 21913101 [TBL] [Abstract][Full Text] [Related]
46. Behavioral Phenotyping Assays for Genetic Mouse Models of Neurodevelopmental, Neurodegenerative, and Psychiatric Disorders. Sukoff Rizzo SJ; Crawley JN Annu Rev Anim Biosci; 2017 Feb; 5():371-389. PubMed ID: 28199172 [TBL] [Abstract][Full Text] [Related]
47. Uses for humanised mouse models in precision medicine for neurodegenerative disease. Nair RR; Corrochano S; Gasco S; Tibbit C; Thompson D; Maduro C; Ali Z; Fratta P; Arozena AA; Cunningham TJ; Fisher EMC Mamm Genome; 2019 Aug; 30(7-8):173-191. PubMed ID: 31203387 [TBL] [Abstract][Full Text] [Related]
48. Mini-review: Retarding aging in murine genetic models of neurodegeneration. Albin RL; Miller RA Neurobiol Dis; 2016 Jan; 85():73-80. PubMed ID: 26477301 [TBL] [Abstract][Full Text] [Related]
53. Behavioural phenotyping of mouse mutants. van der Staay FJ; Steckler T Behav Brain Res; 2001 Nov; 125(1-2):3-12. PubMed ID: 11682087 [TBL] [Abstract][Full Text] [Related]
54. Strategies for Behaviorally Phenotyping the Transgenic Mouse. McCarson KE Methods Mol Biol; 2020; 2066():171-194. PubMed ID: 31512217 [TBL] [Abstract][Full Text] [Related]
55. The complexities of behavioural assessment in neurodegenerative disorders: A focus on Alzheimer's disease. Commins S; Kirby BP Pharmacol Res; 2019 Sep; 147():104363. PubMed ID: 31374247 [TBL] [Abstract][Full Text] [Related]
56. Building a better mouse test. Nat Methods; 2011 Sep; 8(9):697. PubMed ID: 21984997 [TBL] [Abstract][Full Text] [Related]
58. Current trends in tauopathy research: from disease modelling to therapeutic approaches. Frank S; Tolnay M Neuropathol Appl Neurobiol; 2015 Feb; 41(1):1-2. PubMed ID: 25630630 [No Abstract] [Full Text] [Related]
59. Practical and theoretical issues in gene-targeting studies and their application to behaviour. Hagan JJ; Harper AJ; Elliott H; Jones DN; Rogers DC Rev Neurosci; 2000; 11(1):3-13. PubMed ID: 10716650 [TBL] [Abstract][Full Text] [Related]
60. A Simple and Fast Battery Test for Phenotypic Characterization of Mice. Garcia-Gomes MSA; Zanatto DA; Yamamoto PK; Wadt D; Antiorio ATFB; Aleman-Laporte J; Alexandre-Ribeiro SR; Marson GA; Guizzo C; Massironi SMG; Bernardi MM; Mori CMC Bio Protoc; 2020 Apr; 10(7):e3568. PubMed ID: 33659538 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]